Arrowhead Research | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Agios Pharmaceuticals USD 45.87M 4.34M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Arrowhead Research USD 30.95M 3.06M 2025-06
Incyte USD 331.02M 5.33M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
Ligand Pharmaceuticals USD 20.18M 1.37M 2025-06
Merck USD 2.63B 104M 2025-06
Moderna USD 230M 18M 2025-06
Novartis USD 3.44B 384M 2025-06
Sarepta Therapeutics USD 69.89M 63.74M 2025-06
TG Therapeutics USD 12.04M 38.29M 2025-06
Ultragenyx Pharmaceutical USD 86.65M 1.15M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06
Xencor USD 15.11M 2.22M 2025-06


Arrowhead Research Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.